Total Payments
$770,098
2024 Payments
$36,149
Companies
27
Transactions
1,314
Medicare Patients
2,416
Medicare Billing
$245,201
Payment Breakdown by Category
Other$577,490 (75.0%)
Travel$85,059 (11.0%)
Consulting$77,135 (10.0%)
Food & Beverage$30,160 (3.9%)
Education$214.47 (0.0%)
Gifts$40.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $576,240 | 303 | 74.8% |
| Travel and Lodging | $85,059 | 351 | 11.0% |
| Consulting Fee | $77,135 | 30 | 10.0% |
| Food and Beverage | $30,160 | 615 | 3.9% |
| Honoraria | $1,250 | 1 | 0.2% |
| Education | $214.47 | 13 | 0.0% |
| Gift | $40.59 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $132,302 | 244 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $120,831 | 107 | $0 (2023) |
| Celgene Corporation | $91,984 | 168 | $0 (2019) |
| ABBVIE INC. | $89,013 | 225 | $0 (2024) |
| Lilly USA, LLC | $77,266 | 136 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $63,962 | 46 | $0 (2024) |
| Genentech USA, Inc. | $58,926 | 42 | $0 (2024) |
| PFIZER INC. | $39,459 | 92 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $37,300 | 56 | $0 (2019) |
| GENZYME CORPORATION | $28,652 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,149 | 92 | Mallinckrodt Hospital Products Inc. ($19,145) |
| 2023 | $34,456 | 87 | ABBVIE INC. ($15,736) |
| 2022 | $50,136 | 90 | ABBVIE INC. ($15,228) |
| 2021 | $35,601 | 61 | Mallinckrodt Hospital Products Inc. ($15,000) |
| 2020 | $64,083 | 87 | Mallinckrodt Hospital Products Inc. ($18,860) |
| 2019 | $209,605 | 298 | Mallinckrodt Enterprises LLC ($37,165) |
| 2018 | $186,078 | 305 | Janssen Scientific Affairs, LLC ($44,647) |
| 2017 | $153,990 | 294 | Celgene Corporation ($47,566) |
All Payment Transactions
1,314 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | Cash or cash equivalent | $132.66 | General |
| Category: Inflammation | ||||||
| 12/18/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | In-kind items and services | $286.63 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $46.15 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $122.62 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,040.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $117.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $311.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $301.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | In-kind items and services | $285.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Dermatology | ||||||
| 10/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $132.05 | General |
| Category: Rheumatology | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 614 | 1,210 | $384,435 | $66,455 |
| 2022 | 5 | 617 | 1,222 | $385,300 | $66,294 |
| 2021 | 7 | 593 | 1,367 | $412,035 | $68,698 |
| 2020 | 7 | 592 | 1,092 | $326,253 | $43,754 |
Total Patients
2,416
Total Services
4,891
Medicare Billing
$245,201
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 328 | 742 | $204,050 | $38,548 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 178 | 278 | $111,200 | $20,762 | 18.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 40 | 87 | $40,020 | $3,615 | 9.0% |
| 20600 | Aspiration and/or injection of fluid from small joint | Facility | 2023 | 24 | 48 | $16,320 | $1,199 | 7.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 15 | 18 | $4,950 | $1,008 | 20.4% |
| 20550 | Injection into tendon or ligament | Facility | 2023 | 17 | 24 | $4,320 | $685.84 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $3,575 | $636.06 | 17.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 344 | 820 | $225,500 | $42,163 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 141 | 191 | $76,400 | $15,792 | 20.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2022 | 65 | 121 | $55,660 | $5,247 | 9.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 38 | 44 | $12,100 | $1,660 | 13.7% |
| 20600 | Aspiration and/or injection of fluid from small joint | Facility | 2022 | 29 | 46 | $15,640 | $1,433 | 9.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 358 | 980 | $269,500 | $52,056 | 19.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Facility | 2021 | 68 | 133 | $61,180 | $5,516 | 9.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 47 | 56 | $22,400 | $4,529 | 20.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 67 | 81 | $22,275 | $3,534 | 15.9% |
| 20600 | Aspiration and/or injection of small joint or joint capsule | Facility | 2021 | 29 | 83 | $28,220 | $2,055 | 7.3% |
| 20550 | Injections of tendon sheath, ligament, or muscle membrane | Facility | 2021 | 12 | 21 | $3,780 | $602.41 | 15.9% |
| 20605 | Aspiration and/or injection of medium joint or joint capsule | Facility | 2021 | 12 | 13 | $4,680 | $406.36 | 8.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 358 | 744 | $204,600 | $29,968 | 14.6% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Facility | 2020 | 73 | 117 | $53,820 | $4,890 | 9.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 44 | 51 | $20,400 | $3,299 | 16.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 63 | 73 | $16,353 | $3,099 | 19.0% |
| 20600 | Aspiration and/or injection of small joint or joint capsule | Facility | 2020 | 25 | 75 | $25,500 | $1,720 | 6.7% |
| 20550 | Injections of tendon sheath, ligament, or muscle membrane | Facility | 2020 | 12 | 14 | $2,520 | $396.17 | 15.7% |
About Dr. Glenn Ehresmann, M.D
Dr. Glenn Ehresmann, M.D is a Rheumatology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043248727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Ehresmann, M.D has received a total of $770,098 in payments from pharmaceutical and medical device companies, with $36,149 received in 2024. These payments were reported across 1,314 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($576,240).
As a Medicare-enrolled provider, Ehresmann has provided services to 2,416 Medicare beneficiaries, totaling 4,891 services with total Medicare billing of $245,201. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Los Angeles, CA
- Active Since 06/29/2006
- Last Updated 11/27/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1043248727
Products in Payments
- Otezla (Drug) $116,705
- ACTHAR (Biological) $101,025
- STELARA (Biological) $99,774
- Enbrel (Biological) $84,685
- Actemra (Biological) $45,494
- RINVOQ (Biological) $42,904
- OLUMIANT (Drug) $40,517
- XELJANZ (Drug) $35,695
- SIMPONI ARIA (Biological) $20,782
- TALTZ (Drug) $18,311
- KEVZARA (Drug) $17,856
- Humira (Biological) $15,477
- RINVOQ (Drug) $10,645
- Rinvoq (Biological) $9,308
- NO PRODUCT DISCUSSED (Drug) $8,191
- KEVZARA (Biological) $7,241
- Otezla (Biological) $7,237
- TREMFYA (Drug) $6,227
- DUZALLO (Drug) $5,779
- HUMIRA (Biological) $3,401
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Los Angeles
Dr. Daniel Arkfeld, M.d, M.D
Rheumatology — Payments: $570,588
Rheumatology $570,588
Maureen Mcmahon, Md, MD
Rheumatology — Payments: $327,802
Rheumatology $327,802
Jon Giles, M.d, M.D
Rheumatology — Payments: $285,629
Rheumatology $285,629
Christina Charles-Schoeman, Md, MD
Rheumatology — Payments: $281,888
Rheumatology $281,888
Thomas Romano, M.d, M.D
Rheumatology — Payments: $230,456
Rheumatology $230,456
Gary Feldman, Md, MD
Rheumatology — Payments: $191,160
Rheumatology $191,160